This content is machine translated From high-dose chemotherapy to gene expression. Developments in adjuvant chemotherapy of breast carcinoma. The use of multigene testing is currently limited to the adjuvant setting in HER2-negative luminal breast carcinoma and allows reproducible predictions of recurrence risk. The tests will lead to fewer…
